Literature DB >> 3840540

EQUIL2: a BASIC computer program for the calculation of urinary saturation.

P G Werness, C M Brown, L H Smith, B Finlayson.   

Abstract

A BASIC computer program for the calculation of urinary supersaturation with respect to the common kidney stone components is described. In vitro and in vivo tests show that the program described accurately calculates supersaturation. The application of this computer program to urolithiasis research is discussed.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3840540     DOI： 10.1016/s0022-5347(17)47703-2

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  133 in total

1.  Impact of hypoxia and hypercapnia on calcium oxalate toxicity in renal epithelial and interstitial cells.

Authors:  Yanwei Cao; Sreedhar Sagi; Axel Häcker; Annette Steidler; Peter Alken; Thomas Knoll
Journal:  Urol Res       Date:  2006-04-22

2.  The many roles of oxalate in nature.

Authors:  Lynwood H Smith
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

3.  Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.

Authors:  John C Lieske; William J Tremaine; Claudio De Simone; Helen M O'Connor; Xujian Li; Eric J Bergstralh; David S Goldfarb
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

4.  Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.

Authors:  Andrew P Evan; James E Lingeman; Elaine M Worcester; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Carrie L Philips; Fredric L Coe
Journal:  Kidney Int       Date:  2010-04-28       Impact factor: 10.612

5.  Membrane-associated crystallization of calcium oxalate in vitro.

Authors:  S R Khan; P N Shevock; R L Hackett
Journal:  Calcif Tissue Int       Date:  1990-02       Impact factor: 4.333

6.  Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.

Authors:  Matteo Bargagli; Nasser A Dhayat; Manuel Anderegg; Mariam Semmo; Uyen Huynh-Do; Bruno Vogt; Pietro Manuel Ferraro; Daniel G Fuster
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 8.237

7.  Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1.

Authors:  N Laube; B Hoppe; A Hesse
Journal:  Urol Res       Date:  2005-09-08

8.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

9.  Demographic characteristics and metabolic risk factors in Croatian children with urolithiasis.

Authors:  Danko Milošević; Danica Batinić; Daniel Turudić; Danko Batinić; Marija Topalović-Grković; Ivan Pavao Gradiški
Journal:  Eur J Pediatr       Date:  2013-10-06       Impact factor: 3.183

10.  Inhibition of calcium oxalate crystallization by commercial human serum albumin and human urinary albumin isolated from two different race groups: evidence for possible molecular differences.

Authors:  Allen L Rodgers; Priscilla D Mensah; Sylva L Schwager; Edward D Sturrock
Journal:  Urol Res       Date:  2006-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.